title: Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia.
abstract: The guinea pig does not undergo peroxisome proliferation in response to peroxisome proliferators, in contrast with other rodents. To understand the molecular basis of this phenotype, the peroxisome proliferator activated receptor alpha (PPARalpha) from guinea-pig liver was cloned; it encodes a protein of 467 amino acid residues that is similar to rodent and human PPARalpha. The guinea-pig PPARalpha showed a high substitution rate: maximum likelihood analysis was consistent with rodent monophyly, but could not exclude rodent polyphyly (P approximately 0.06). The guinea-pig PPARalpha cDNA was expressed in 293 cells and mediated the induction of the luciferase reporter gene by the peroxisome proliferator, Wy-14,643, dependent on the presence of a peroxisome proliferator response element. Moreover the PPARalpha RNA and protein were expressed in guinea-pig liver, although at lower levels than in a species which is responsive to peroxisome proliferators, the mouse. To determine whether the guinea-pig PPARalpha mediated any physiological effects, guinea pigs were exposed to two selective PPARalpha agonists, Wy-14, 643 and methylclofenapate; both compounds induced hypolipidaemia. Thus the guinea pig is a useful model for human responses to peroxisome proliferators.
authors.affiliation: School of Biology, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
authors.forename: A R
authors.initials: AR
authors.lastname: Bell
authors.forename: R
authors.initials: R
authors.lastname: Savory
authors.forename: N J
authors.initials: NJ
authors.lastname: Horley
authors.forename: A I
authors.initials: AI
authors.lastname: Choudhury
authors.forename: M
authors.initials: M
authors.lastname: Dickins
authors.forename: T J
authors.initials: TJ
authors.lastname: Gray
authors.forename: A M
authors.initials: AM
authors.lastname: Salter
authors.forename: D R
authors.initials: DR
authors.lastname: Bell
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002992:Clofenapate / Q000494:pharmacology*; D003001:Cloning, Molecular; D006224:Cricetinae; D018076:DNA, Complementary / Q000096:biosynthesis / Q000737:chemistry; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008055:Lipids / Q000097:blood*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D051379:Mice; D008810:Mice, Inbred C57BL; D008830:Microbodies / Q000187:drug effects* / Q000378:metabolism; D008969:Molecular Sequence Data; D011743:Pyrimidines / Q000494:pharmacology*; D051381:Rats; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists / Q000235:genetics / Q000502:physiology*; D016415:Sequence Alignment; D014157:Transcription Factors / Q000819:agonists / Q000235:genetics / Q000502:physiology*; D014981:Xenopus
chemical_list: D018076:DNA, Complementary; D000960:Hypolipidemic Agents; D008055:Lipids; D011743:Pyrimidines; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D002992:Clofenapate; C006253:pirinixic acid